Alliancebernstein L.P. Evolus, Inc. Transaction History

Alliancebernstein L.P.

$290 Billion
Q2 2025

A detailed history of Alliancebernstein L.P. transactions in Evolus, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 62,440 shares of EOLS stock, worth $399,616. This represents 0.0% of its overall portfolio holdings.

Number of Shares

62,440

Previous 62,440 -0.0%

Holding current value

$399,616

Previous $751,000 23.44%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 May 14, 2024	BUY	$9.99 - $14.91 $39,560 - $59,043	3,960 Added 6.77%	62,440 $874,000
Q4 2023 Feb 14, 2024	SELL	$7.6 - $10.53 $50,008 - $69,287	-6,580 Reduced 10.11%	58,480 $615,000
Q3 2023 Nov 14, 2023	BUY	$7.15 - $10.2 $715 - $1,019	100 Added 0.15%	65,060 $594,000
Q2 2023 Aug 15, 2023	BUY	$7.23 - $10.52 $95,146 - $138,443	13,160 Added 25.41%	64,960 $472,000
Q4 2022 Feb 14, 2023	BUY	$6.52 - $8.95 $24,776 - $34,010	3,800 Added 7.92%	51,800 $389,000
Q3 2022 Nov 15, 2022	SELL	$7.76 - $13.72 $277,846 - $491,244	-35,805 Reduced 42.72%	48,000 $386,000
Q2 2022 Aug 15, 2022	BUY	$10.22 - $13.94 $418,049 - $570,215	40,905 Added 95.35%	83,805 $972,000
Q1 2022 May 13, 2022	BUY	$5.22 - $11.78 $1,044 - $2,356	200 Added 0.47%	42,900 $481,000
Q2 2021 Jul 30, 2021	BUY	$8.42 - $13.96 $44,626 - $73,988	5,300 Added 14.17%	42,700 $540,000
Q1 2021 May 06, 2021	SELL	$3.2 - $16.51 $88,320 - $455,676	-27,600 Reduced 42.46%	37,400 $486,000
Q3 2020 Nov 12, 2020	SELL	$3.03 - $5.48 $3,333 - $6,028	-1,100 Reduced 1.66%	65,000 $254,000
Q2 2020 Aug 13, 2020	BUY	$3.53 - $6.17 $35,300 - $61,700	10,000 Added 17.83%	66,100 $350,000
Q1 2020 May 14, 2020	BUY	$3.53 - $12.21 $57,892 - $200,244	16,400 Added 41.31%	56,100 $233,000
Q3 2019 Nov 14, 2019	BUY	$13.91 - $19.87 $80,678 - $115,246	5,800 Added 17.11%	39,700 $620,000
Q2 2019 Aug 14, 2019	BUY	$13.19 - $28.36 $114,753 - $246,732	8,700 Added 34.52%	33,900 $496,000
Q1 2019 May 14, 2019	SELL	$12.43 - $28.91 $52,206 - $121,422	-4,200 Reduced 14.29%	25,200 $569,000
Q4 2018 Feb 13, 2019	BUY	$10.57 - $19.29 $76,104 - $138,888	7,200 Added 32.43%	29,400 $350,000
Q3 2018 Nov 08, 2018	BUY	$17.31 - $29.82 $76,164 - $131,208	4,400 Added 24.72%	22,200 $413,000
Q2 2018 Aug 13, 2018	BUY	$6.85 - $38.49 $121,930 - $685,122	17,800 New	17,800 $498,000

Others Institutions Holding EOLS

# of Institutions

186

Shares Held

55.6M

Call Options Held

1.21M

Put Options Held

48.5K

View Full List

About Evolus, Inc.

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $359M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

More about EOLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Evolus, Inc. Transaction History